Hormone replacement therapy formulations and risk of epithelial ovarian carcinoma. (Q53824136)
scientific article
Language:
Current Data About Hormone replacement therapy formulations and risk of epithelial ovarian carcinoma.
(P31) (Q13442814)
(P248)
(P698) 12144815
(P813) Sunday, May 20, 2018
(P854) http://europepmc.org/abstract/MED/12144815

(P50) (Q30831502)
(P1545) 2
(P1932) Francesmary Modugno
(P248)
(P698) 12144815
(P813) Sunday, May 20, 2018

(Q97311751)
(P1545) 5
(P1932) Roberta B Ness
(P248)
(P698) 12144815
(P813) Sunday, May 20, 2018
(P854) http://europepmc.org/abstract/MED/12144815

(P304) 118-123
(P248)
(P698) 12144815
(P813) Sunday, May 20, 2018
(P854) http://europepmc.org/abstract/MED/12144815

(P407) (Q1860)

(P433) 2
(P248)
(P698) 12144815
(P813) Sunday, May 20, 2018
(P854) http://europepmc.org/abstract/MED/12144815

(P478) 86
(P248)
(P698) 12144815
(P813) Sunday, May 20, 2018
(P854) http://europepmc.org/abstract/MED/12144815

(P577) Thursday, August 1, 2002
(P248)
(P698) 12144815
(P813) Sunday, May 20, 2018
(P854) http://europepmc.org/abstract/MED/12144815

(P921) (Q108667313)
(P887)

(P1433) (Q5625182)
(P248)
(P698) 12144815
(P813) Sunday, May 20, 2018
(P854) http://europepmc.org/abstract/MED/12144815

(P1476) "Hormone replacement therapy formulations and risk of epithelial ovarian carcinoma." (language: en)
(P248)
(P698) 12144815
(P813) Sunday, May 20, 2018
(P854) http://europepmc.org/abstract/MED/12144815

(P2093) Anita S Y Sit
(P1545) 1
(P248)
(P698) 12144815
(P813) Sunday, May 20, 2018
(P854) http://europepmc.org/abstract/MED/12144815

Joel L Weissfeld
(P1545) 3
(P248)
(P698) 12144815
(P813) Sunday, May 20, 2018
(P854) http://europepmc.org/abstract/MED/12144815

Sarah L Berga
(P1545) 4
(P248)
(P698) 12144815
(P813) Sunday, May 20, 2018
(P854) http://europepmc.org/abstract/MED/12144815

other details
description scientific article

External Links
(P356) 10.1006/GYNO.2002.6746
(P698) 12144815
(P5875) 11237251